Cellular Immunotherapy for Immune Tolerance in Past Recipients of HLA Zero-mismatch, Living Donor Kidney Transplants

NCT03606746 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Lack of funding

Conditions

Kidney Transplant Rejection

Interventions

BIOLOGICAL: MDR-103

Sponsor

Medeor Therapeutics, Inc.